93 related articles for article (PubMed ID: 37475053)
1. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.
Tan PS; Koh E; Pang C; Ong WS; Ngo L; Soh LT; Quek R; Chay WY; Ho TH; Tay SK; Chew SH; Lim-Tan SK; Khoo-Tan H; Lim SL; Busmanis I; Goh LK; Chia YN; Chia WK; Lim T
Oncologist; 2012; 17(10):1286-93. PubMed ID: 22829569
[TBL] [Abstract][Full Text] [Related]
3. Application of 3.0 T multimodal MRI in FIGO staging of cervical cancer.
Pan L; Shan RY; Gao SF; Zhou Y; Bao YY; Fu W
Technol Health Care; 2024; 32(2):823-830. PubMed ID: 37393459
[TBL] [Abstract][Full Text] [Related]
4. Nomogram based on MRI and clinical features to predict progression-free survival in patients with stage IIIC1r cervical squamous cell carcinoma: A two-center study.
Luo WX; Ding XM; Cheng JM; Liu X; Zhou HY
Clin Radiol; 2024 Apr; ():. PubMed ID: 38749826
[TBL] [Abstract][Full Text] [Related]
5. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
[TBL] [Abstract][Full Text] [Related]
6. High keratin 15 expression reflects favorable prognosis in early cervical cancer patients.
Zhou L; Bi Y; Wu X; He H
Ir J Med Sci; 2024 Apr; ():. PubMed ID: 38639842
[TBL] [Abstract][Full Text] [Related]
7. A model to guide the management and decision of re-planning during radiotherapy for cervical cancer.
Zhang W; Li X; Lin T; Ma F; Ma X; Wu X; Sun Y; Sun X
Transl Cancer Res; 2021 Dec; 10(12):5352-5363. PubMed ID: 35116382
[TBL] [Abstract][Full Text] [Related]
8. Does "One Size Fits All"? Rethinking FIGO Depth of Invasion Measurements in Vulvar Cancer.
Bleeker MCG; Bosse T; van de Vijver KK; Bart J; Horlings H; Jonges TGN; Visser NCM; Kooreman LFS; Bulten J; Ewing-Graham PC
Int J Gynecol Pathol; 2024 Feb; ():. PubMed ID: 38303108
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in laryngeal squamous cell carcinoma.
Bradford CR; Ferlito A; Devaney KO; Mäkitie AA; Rinaldo A
Laryngoscope Investig Otolaryngol; 2020 Feb; 5(1):74-81. PubMed ID: 32128433
[TBL] [Abstract][Full Text] [Related]
10. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
11. Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.
Saleh M; Virarkar M; Javadi S; Elsherif SB; de Castro Faria S; Bhosale P
AJR Am J Roentgenol; 2020 May; 214(5):1182-1195. PubMed ID: 32182097
[No Abstract] [Full Text] [Related]
12. Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.
Parisi S; Sciacca M; Ferrantelli G; Chillari F; Critelli P; Venuti V; Lillo S; Arcieri M; Martinelli C; Pontoriero A; Minutoli F; Ercoli A; Pergolizzi S
Jpn J Radiol; 2024 Apr; 42(4):354-366. PubMed ID: 37987880
[TBL] [Abstract][Full Text] [Related]
13. A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy.
Zang L; Chen Q; Lin A; Chen J; Zhang X; Fang Y; Wang M
World J Surg Oncol; 2023 Jul; 21(1):210. PubMed ID: 37475053
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
